MLchartDataset catalogue

14C BMS-275183

Term · Oncology and biomedicine · MLC-T-ONC-009516

An orally bioavailable taxane compound, a C-4 methyl carbonate analogue of paclitaxel, labeled with radioactive carbon 14, with potential antineoplastic and radioimaging activities. BMS-275183 binds to tubulin and as a result inhibits microtubule disassembly or assembly. This leads to cell cycle arrest at the G2/M phase, thereby resulting in an inhibition of cell division and ultimately cell death. BMS-275183 may be useful for treating multi-drug resistant tumors as it does not appear to be a substrate for P-glycoprotein.

Table 1. Record
IdentifierMLC-T-ONC-009516
FieldOncology and biomedicine
Synonyms[14C] BMS-275183
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009516",
  "term": "14C BMS-275183",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable taxane compound, a C-4 methyl carbonate analogue of paclitaxel, labeled with radioactive carbon 14, with potential antineoplastic and radioimaging activities. BMS-275183 binds to tubulin and as a result inhibits microtubule disassembly or assembly. This leads to cell cycle arrest at the G2/M phase, thereby resulting in an inhibition of cell division and ultimately cell death. BMS-275183 may be useful for treating multi-drug resistant tumors as it does not appear to be a substrate for P-glycoprotein.",
  "synonyms": [
    "[14C] BMS-275183"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/14c-bms-275183/"
}

Record 19 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.